Updated phase III results from the BEACON study have found that encorafenib with cetuximab can lead to promising survival outcomes among patients with advanced colorectal cancer (CRC) who had received […]
In 1999, the Prevent Cancer Foundation designated March as the National Colorectal Cancer Awareness Month. The foundation partnered with the American Digestive Health Foundation and the National Colorectal Cancer Roundtable […]
Colorectal cancer (CRC) is the third most common cancer in terms of incidence and mortality in both males and females in the U.S. Screening remains the best method to detect […]
Aspirin is a non-steroidal anti-inflammatory drug (NSAIDs) that is commonly used as a pain reliever, antipyretic (fever reducer), and preventative medication for cardiovascular illnesses. It is cost-effective, generic, and available […]
March is National Colorectal Cancer Awareness Month—an observance of patients, survivors, caregivers, and advocates to educate their communities about the disease. It is also an opportune time to promote awareness […]
Colorectal cancer (CRC) is the leading gastrointestinal neoplasia, which has historically been known to primarily affect individuals over 50 years of age, and screening is currently recommended for those 50 […]
The ongoing COVID-19 pandemic has affected elective colorectal cancer (CRC) surgical practices, and its impact on mortality after CRC surgical resections has been slowly emerging. Early on, studies done in […]
A shared decision-making tool is an approach that allows the clinician to collaborate with the patient in reaching evidence-informed decision making. This tool permits the patient and the physician to […]
Numerous challenges present themselves when a patient chooses to get screened for colorectal cancer (CRC), but we know very little about why patients may opt-out of getting screened. A survey […]